Herpes zoster vaccine effective in older adults

Monday 21 August 2017

Brian McAvoy

PEARLS No.

511

Clinical question

Compared with placebo or no vaccine, how effective is vaccination for preventing herpes zoster in older adults?

Bottom line

Moderate-quality evidence suggests, in persons of 60 years of age or older, the herpes zoster vaccine reduced the incidence of herpes zoster for at least 3 years post vaccination (NNT* 50). The vaccinated group had a higher incidence of mild-to-moderate intensity adverse events (mild-to-moderate symptoms at the injection site). Refrigerated vaccines caused fewer injection site adverse effects than frozen vaccines. The injection of the vaccine into the muscle caused fewer adverse effects than when it was injected subcutaneously. (*NNT = number needed to treat to benefit 1 individual.)

Caveat

All included studies were conducted in high-income countries and included only healthy, elderly, Caucasian participants (age >60 years) with no immunosuppressive problems. Pharmaceutical companies that produce the vaccines funded all of the included studies.

Context

The natural process of ageing is associated with a reduction in cellular immunity, and this predisposes older people to herpes zoster. Vaccination with an attenuated form of varicella zoster virus activates specific T-cell production, avoiding viral reactivation.

Cochrane Systematic Review

Gagliardi AMZ et al. Vaccines for preventing herpes zoster in older adults. Cochrane Reviews, 2016, Issue 3. Art. No.: CD008858.DOI: 10.1002/14651858. CD008858.pub3. This review contains 13 studies involving 69,916 participants.

Cochrane Systematic Reviews for primary care practitioners
Developed by the Cochrane Primary Care Field, New Zealand Branch of the Australasian Cochrane Centre at the Department of General Practice and Primary Health Care, University of Auckland and funded by the Ministry of Health and New Zealand Doctor. PEARLS are meant for educational use and not to guide clinical care. New Zealanders can access the Cochrane Library free via www.cochrane.org.nz

PEARLS archive

How to Treat

Paediatric eczema

Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management

Wednesday 14 August 2024, 12:45 AM